Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
about
Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinicManagement of Mycoplasma genitalium infections - can we hit a moving target?Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutationsAntimicrobial Susceptibility Patterns of Recent Cuban Mycoplasma genitalium Isolates Determined by a Modified Cell-Culture-Based MethodIn vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.Mycoplasma genitalium: from Chrysalis to multicolored butterfly.In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium2015 UK National Guideline on the management of non-gonococcal urethritis.Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts.Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan.Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis.New Horizons in Mycoplasma genitalium Treatment.Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections.Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium.Multidrug-resistant Mycoplasma genitalium infections in Europe.Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.Mycoplasma genitalium infections: current treatment options and resistance issues.Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan.Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
P2860
Q21133562-A503EB19-3C04-4F27-8F9D-143692D4F91AQ26796722-1E2F9AE9-1FCF-4A2C-BF50-238D9F97D5F3Q27021073-23446CAC-9BCF-4930-83A8-B6D494961190Q28554374-9A1C8CB9-D177-4DAE-8CA2-8959BC6BDC01Q33797838-BE85301D-C582-4067-A0DB-49C82C62DC3CQ35090137-B9809FD1-7789-4355-9626-29CC5D46975BQ35168864-0D37DB6F-527D-4901-BF6F-7C14D26AF9B4Q35656598-BE9FD3B1-A46E-4819-9900-D54B0B0B6A29Q36337074-B1F8E1B6-C489-4E0E-B961-32FF257759E0Q36971250-317D8860-95D6-40BE-8FA9-74ABAE4DD755Q37840512-7B1AC9E1-50DD-47B5-837D-64192F64F872Q37844334-18956988-743B-4C0D-A067-3C501E3FD15EQ37846695-46E7BEFF-91B2-4641-920C-3FC8B4706C9EQ38040151-8F0EA539-172F-42B0-914B-B081C7558742Q38609857-EA975B02-CB28-4022-9D73-0C431E0F4D9AQ38646438-E54ACC69-2C84-4026-9F32-7924C5F1E37FQ38772340-95FA6031-AD6D-4B47-9977-306225597DC4Q40271087-19F71DB2-1725-4381-A63A-CA3D356E56ACQ40359795-364F2090-4314-4DF7-8B65-1C6FD24D137CQ42212384-9E624938-1F33-4D31-9D8E-D5CADF818F92Q42355223-C9D53137-891F-4637-A738-3AD4710FABABQ43180518-4F7DDC0E-E6FD-490F-A921-B04B685FE73FQ55234408-28F147E0-A6B6-4ED1-84C3-0B92724360B1
P2860
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@en
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@nl
type
label
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@en
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@nl
prefLabel
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@en
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@nl
P2860
P356
P1476
Antimicrobial susceptibilities ...... dilution and quantitative PCR.
@en
P2093
Ryoichi Hamasuna
Yukio Osada
P2860
P304
P356
10.1128/AAC.00724-09
P407
P577
2009-09-08T00:00:00Z